Responses
Other content recommended for you
- Do we really know how many clinical trials are conducted ethically? Why research ethics committee review practices need to be strengthened and initial steps we could take to strengthen them
- First - in - human HIV - remission studies: reducing and justifying risk
- Mapping the preclinical to clinical evidence and development trajectory of the oncolytic virus talimogene laherparepvec (T - VEC): a systematic review
- Contractualist reasoning, HIV cure clinical trials, and the moral (ir) relevance of the risk / benefit ratio
- ‘ Rethinking “ Disease ”: a fresh diagnosis and a new philosophical treatment ’
- T-cell agonists in cancer immunotherapy
- Advancing clinical development pathways for new CFTR modulators in cystic fibrosis
- T lymphocyte - targeted immune checkpoint modulation in glioma
- Oxford vaccine study highlights pick and mix approach to preclinical research
- Intraocular pressure efficacy of glaucoma medications versus placebo in phase II compared to later phase trials